NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/11/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
EVOC
ST13
US500000079258342Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Feng Shan SZDC Law PC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable and recorded computer software and computer programs to control collection of medical samples by modifying the timing of data collection and to perform analysis of medical samples in connection with and as part of medical apparatus; Downloadable and recorded computer application software for hand-held computing devices, namely, software to control collection of medical samples and to perform analysis of medical samples for use in connection with and as part of medical apparatus and instruments; Downloadable and recorded medical diagnostic software for use to control collection of medical samples and to perform analysis of medical samples in connection with and as part of medical apparatus and instruments; Chemical detection systems and apparatus, namely, analyzers and sampling equipment for use to collect and analyze liquid, solid and gas samples; gas detectors for detecting the presence of gas; Particle counters; Pressure sensors; Downloadable and recorded computer software and computer programs for medical purposes for use to diagnose and monitor diseases in connection with and as part of medical apparatus and instruments; replacement parts and fittings for all of the aforesaid; none of the aforesaid relating to dermatology or skincare; none of the aforesaid relating to vehicles or the automotive industry
Classe 10
Medical apparatus and instruments for treating cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; Diagnostic apparatus for medical purposes for detecting cancer cells; Chemical detection systems and apparatus for medical purposes, namely, analyzers and sampling equipment for use to collect and analyze liquid, solid and gas samples; Medical imaging apparatus; Medical and clinical devices used for the collection, recording, concentration and analysis of volatile organic compounds in human breath; Medical testing kits in the nature of a medical device for detection of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease for home use; Respiratory equipment for medical purposes; Testing apparatus for medical purposes, namely, breath detectors for use to detect disease biomarkers; Detectors for medical purposes, namely, breath detectors for use to detect disease biomarkers; Sensors for medical purposes, namely, respiratory sensors; Replacement parts and fittings for all of the aforesaid; none of the aforesaid relating to dermatology or skincare; none of the aforesaid goods being related to hip prosthesis or orthopaedic articles
Classe 42
Medical research services; Clinical research services in the field of disease biomarkers; Chemical analysis; Chemical research; Analytical laboratory services in the field of disease biomarkers; Biological analysis; Laboratory analysis in the field of disease biomarkers; Scientific laboratory services; Laboratory testing services of disease biomarkers within gas, liquid and solid samples; Medical research laboratory services; Design and development of medical technology and medical apparatus research and development services relating to medical apparatus and instruments; Advice, information and consultancy relating to any of the aforesaid scientific laboratory services; none of the aforesaid relating to dermatology or skincare; none of the aforesaid relating to vehicles or the automotive industry
Classe 44
Medical services; Consulting services relating to health care; Healthcare services; health advice and information services; Medical care services; Medical clinic services; health clinic services; Medical health assessment services; Health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; Diagnostic health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; providing health information in the form of preparing reports relating to health matters; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic purposes; Genetic testing for medical purposes; advice, information and consultancy services relating to any of the aforesaid medical services; none of the aforesaid relating to dermatology or skincare
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
NEW REPRESENTATIVE AT IB RECEIVED
13/11/2025
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
14/07/2025
FINAL DECISION TRANSACTION PROCESSED BY IB
21/11/2020
FINAL DISPOSITION NOTICE SENT TO IB
04/11/2020
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
04/11/2020
FINAL DISPOSITION PROCESSED
04/11/2020
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/10/2020
REGISTERED-PRINCIPAL REGISTER
14/07/2020
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
04/06/2020
LIMITATION OF GOODS RECEIVED FROM IB
01/05/2020
EXTENSION OF TIME TO OPPOSE RECEIVED
16/04/2020
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/03/2020
PUBLISHED FOR OPPOSITION
17/03/2020
NOTIFICATION PROCESSED BY IB
13/03/2020
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/02/2020
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
26/02/2020
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/02/2020
ASSIGNED TO LIE
13/02/2020
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2020
EXAMINER'S AMENDMENT ENTERED
10/02/2020
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/02/2020
EXAMINERS AMENDMENT E-MAILED
10/02/2020
EXAMINERS AMENDMENT -WRITTEN
10/02/2020
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/01/2020
NON-FINAL ACTION E-MAILED
22/01/2020
NON-FINAL ACTION WRITTEN
22/01/2020
TEAS/EMAIL CORRESPONDENCE ENTERED
24/12/2019
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/12/2019
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/12/2019
REFUSAL PROCESSED BY IB
16/08/2019
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/07/2019
REFUSAL PROCESSED BY MPU
26/07/2019
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/07/2019
NON-FINAL ACTION WRITTEN
01/07/2019
APPLICATION FILING RECEIPT MAILED
14/05/2019
ASSIGNED TO EXAMINER
10/05/2019
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/05/2019
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/05/2019
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.